HR 124 · Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
Referred to the House Committee on Energy and Commerce.
- Introduced
- Jan 3, 2025
- Latest action
- Jan 3, 2025
- Sponsor
- Rep. Al Green [D-TX-9]
- Policy area
- Health
- Cosponsors
- 0
Summary
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [ sic ] This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Recent actions
- Jan 3, 2025 Referred to the House Committee on Energy and Commerce.
- Jan 3, 2025 Introduced in House
- Jan 3, 2025 Introduced in House
Votes
No recorded votes are available for this bill.